Objectives: 

1.  Distinguish ST-segment elevation (STE) and non-STE acute coronary syndrome (ACS) by prognosis and treatment strategy.

2.  Devise a pharmacotherapy treatment plan for a patient undergoing primary percutaneous coronary intervention (PCI) for STE myocardial infarction (MI).

Session date: 
Tuesday, February 27, 2018 - 7:30am to 8:30am
Speaker Name: 
Michael Salinger, MD
Location: 
NorthShore - Evanston
Evanston, IL 60201
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.